Are you Dr. Nathan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 22 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Harvard Med Sch
Boston, MA 02115- Is this information wrong?
Summary
- Dr. Carl Nathan, MD is an allergist/immunologist in Boston, Massachusetts. He is currently licensed to practice medicine in New York.
Education & Training
Harvard Medical SchoolClass of 1972
Certifications & Licensure
NY State Medical License 1979 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1998
Clinical Trials
- A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- 12 citationsOxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected.Kohta Saito, Saurabh Mishra, Thulasi Warrier, Nico Cicchetti, Jianjie Mi, Elaina Weber, Xiuju Jiang, Julia Roberts, Alexandre Gouzy, Ellen Kaplan, Christopher D. Brown...> ;Science Translational Medicine. 2021 Nov 24
- Characterization of Phosphopantetheinyl Hydrolase from Mycobacterium tuberculosis.Shilpika Pandey, Amrita Singh, Guangli Yang, Felipe B. d’Andrea, Xiuju Jiang, Travis Hartman, John W. Mosior, Ronnie Bourland, Ben Gold, Julia Roberts, Annie Geiger, S...> ;Microbiology Spectrum. 2021 Sep 22
- 1 citationsSurmounting structural barriers to tackle endemic infectious diseases.Félix Calderón, Alan H. Fairlamb, Mike Strange, Pauline Williams, Carl Nathan> ;The Journal of Experimental Medicine. 2021 Sep 6
- Join now to see all
Press Mentions
Eli Lilly-Backed IpiNovyx Bio Emerges with $10M for 2023 Clinical EntryOctober 5th, 2021- Weill Cornell Advances TB Research with Support from NIHSeptember 3rd, 2021
- Commentary: Multisector Research Collaborative Aims to Advance Tuberculosis TreatmentAugust 4th, 2021
- Join now to see all
Grant Support
- Biology Of Lipoamide Dehydrogenase And 2-Hydroxy-3-Oxoadipate Synthase In MTBNational Institute Of Allergy And Infectious Diseases2011–2012
- Mycobacterial Proteasome InhibitorsNational Institute Of Allergy And Infectious Diseases2009–2010
- Targets In Mycobacterium Tuberculosis: Stress Resistance &RepairNational Institute Of Allergy And Infectious Diseases2007–2009
- Macrophages, Dendritic Cells And PathogensNational Institute Of Allergy And Infectious Diseases2003–2007
- Targets In M. Tuberculosis:Stress Resistance &RepairNational Institute Of Allergy And Infectious Diseases2005–2006
- Dihydrolipoamide Acyltransferase:Target For ChemotherapyNational Institute Of Allergy And Infectious Diseases2004
- Targeting Defenses Of Mycobacterium TuberculosisNational Heart, Lung, And Blood Institute2002–2004
- Role Of NO Synthase-2 In Murine Alzheimer'S DiseaseNational Institute On Aging2000–2004
- Neutrophil Activation In Sepsis-- Role Of PYK2 PathwayNational Institute Of Allergy And Infectious Diseases2000–2004
- Mycobacterial Resistance To Reactive Nitrogen/OxygenNational Heart, Lung, And Blood Institute1999–2003
- Septic Shock In Nitric Oxide Synthase Deficient MiceNational Institute Of General Medical Sciences1996–1999
- Nitric Oxide In Anti-Tuberculous Defense Of The LungNational Heart, Lung, And Blood Institute1996–1997
- General Clinical Research CenterNational Center For Research Resources1996–1997
- Regulation Of Nitric Oxide Synthase In MacrophagesNational Institute Of Allergy And Infectious Diseases1993–1997
- General Clinical Research CenterNational Center For Research Resources1996
- Adhesion-Dependent Neutrophil Respiratory BurstNational Cancer Institute1992–1996
- Macrophage DeactivationNational Cancer Institute1991–1995
- Gordon Conference On PhagocytesNational Institute Of Allergy And Infectious Diseases1993
- Short Term Training In The Health ProfessionsNational Institute Of General Medical Sciences1991–1992
- Oxidative Injury By Human NeutrophilsNational Cancer Institute1987–1991
- Biochemistry Of Cytotoxicity Of Phagocytes &LymphocytesNational Cancer Institute1988–1990
- Biochemical Bases Of Cytotoxicity By Phagocytes And LympNational Cancer Institute1985–1987
- Pharmacologic Subversion Of The Antioxidant Defenses Of Human TumorsNational Cancer Institute1985–1986
- Biochemical Bases Of Cytotoxicity By Phagocytes And LympNational Cancer Institute1985
